Private equity-backed ASC operators are increasingly scaling without buying surgery centers outright, a shift that relies on joint ventures, management contracts and exclusivity agreements, according to an October report from the Private Equity Stakeholder Project. The report describes a new…
Author: Patsy Newitt
A Missouri man was sentenced to 10 years in prison for orchestrating a Medicare fraud scheme that generated more than $174 million in genetic testing claims, according to a Dec. 12 news release from the U.S. Department of Justice. What…
Anesthesiologist Jason Hennes, MD, founder of Anesthesia Data Services and partner at Midwest Anesthesia Partners, joined Becker’s to discuss how a mix of hospital employment shifts, ASC stipend complexity and unreliable manual workflows pushed his group to build a proprietary anesthesia…
A New York physician was sentenced to seven years in prison for his role in a scheme that resulted in more than $24 million in fraudulent claims to Medicare, according to an Oct. 23 Justice Department release. What happened?
From investing in staff to facility upgrades, five ASC leaders joined Becker’s to discuss what their top priorities for investment are heading into 2026. Editor’s note: These responses were edited for clarity and length. Question: What are your ASCs’ top…
Advertisement
Most ASC leaders Becker’s spoke with summed up the 2025 payer environment in a single word: challenging. Four of the five leaders pointed to intensifying prior authorization and referral requirements, rising denials, and shrinking reimbursement, all as supply and operating…
Even as most ASCs remain independent, consolidation is picking up speed, fueled by health systems, payers and private equity firms seeking scale, steadier earnings and tighter alignment with physician practices. The ASC market has become a magnet for health systems,…
Adam Berry, CEO of Woodbury, Minn.-based Summit Orthopedics, told Becker’s he expects 2026 to be the point where macroeconomic pressure collides with a maturing ASC market, with patient demand slowing and expense management becoming a defining competency. Mr. Berry joined…
Jim Freund, managing partner at Physician Transaction Advisors, joined Becker’s to discuss how the biggest surprise he’s seen in the ASC partnership market is from lawmakers and regulators stepping in to block or scrutinize deals he believes are “really for…
ASCs are being squeezed from all sides, with rising expenses and flat reimbursement making the traditional ASC value proposition more difficult to sustain. Leaders point to five major cost pressures reshaping the landscape: 1. Labor costs Labor remains one of…